Login to Your Account

Back to the Future

Financing Comes Full Circle; R&DLP Resurgence in Works?

By Trista Morrison

Monday, November 1, 2010
Private equity-backed royalty deals, a relatively new edition to the biotech world, have already evolved from financing vehicle to strategic portfolio management tool. Now they seem to be evolving again, this time toward earlier-stage project financing, and they're starting to look a little like one of the oldest tricks in biotech's playbook: the Research and Development Limited Partnership (R&DLP).

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription